Early serum free light chain responses following high-dose melphalan and stem cell transplantation (HDM/ SCT) for AL amyloidosis

被引：0
|
作者：
Girnius, S. [1 ]
Tsai, F. [1 ]
Seldin, D. C. [1 ]
Quillen, K. [1 ]
Finn, K. T. [1 ]
Andrea, N. T. [1 ]
Sloan, J. M. [1 ]
Skinner, M. [1 ]
Sanchorawala, V. [1 ]
机构：
[1] Amyloid Treatment & Res Program, Boston, MA USA
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：187 / 188
页数：2
相关论文
共 50 条
  • [1] Early serum free light chain responses following high-dose melphalan and stem cell transplantation for AL amyloidosis predict treatment outcomes.
    Sanchorawala, V
    Wright, DG
    Quillen, K
    Fisher, C
    Skinner, M
    Sedlin, DC
    [J]. BLOOD, 2005, 106 (11) : 339A - 339A
  • [2] Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis
    Sanchorawala, V
    Seldin, DC
    Magnani, B
    Skinner, M
    Wright, DG
    [J]. BONE MARROW TRANSPLANTATION, 2005, 36 (07) : 597 - 600
  • [3] Serum free light chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis.
    Sanchorawala, V
    Wright, DG
    Magnani, B
    Skinner, M
    Seldin, DC
    [J]. BLOOD, 2004, 104 (11) : 270A - 270A
  • [4] Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis
    V Sanchorawala
    D C Seldin
    B Magnani
    M Skinner
    D G Wright
    [J]. Bone Marrow Transplantation, 2005, 36 : 597 - 600
  • [5] Early serum free light chain response after high-dose melphalan and stem cell transplantation predicts hematologic response in AL amyloidosis
    Vanessa Fiorini Furtado
    Dina Brauneis
    Janice Weinberg
    Noon Elhassan
    J. Mark Sloan
    Vaishali Sanchorawala
    [J]. Bone Marrow Transplantation, 2022, 57 : 306 - 308
  • [6] Early Serum Free Light Chain Response after High-Dose Melphalan and Stem Cell Transplantation Predicts Hematologic Response in AL Amyloidosis
    Furtado, Vanessa Fiorini
    Brauneis, Dina
    Sarosiek, Shayna
    Quillen, Karen
    Sanchorawala, Vaishali
    [J]. BLOOD, 2020, 136
  • [7] Early serum free light chain response after high-dose melphalan and stem cell transplantation predicts hematologic response in AL amyloidosis
    Furtado, Vanessa Fiorini
    Brauneis, Dina
    Weinberg, Janice
    Elhassan, Noon
    Sloan, J. Mark
    Sanchorawala, Vaishali
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (02) : 306 - 308
  • [8] Infectious Complications In Patients with AL (Immunoglobulin Light Chain) Amyloidosis Undergoing Treatment with High-Dose Melphalan and Autologous Stem-Cell Transplantation (HDM/SCT)
    Taimur, Sarah
    Nader, Claudia
    Lloyd-Travaglini, Christine
    Seldin, David C.
    Sanchorawala, Vaishali
    [J]. BLOOD, 2011, 118 (21) : 895 - 895
  • [9] Successful treatment of AL amyloidosis patients over age 65 with high-dose melphalan and autologous stem cell transplantation (HDM/SCT).
    Seldin, DC
    Anderson, JJ
    Skinner, M
    Malek, K
    Wright, DG
    Quillen, K
    Sanchorawala, V
    [J]. BLOOD, 2004, 104 (11) : 264A - 264A
  • [10] Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis
    Nguyen, Vina P.
    Landau, Heather
    Quillen, Karen
    Brauneis, Dina
    Shelton, Anthony C.
    Mendelson, Lisa
    Rahman, Hafsa
    Sloan, J. Mark
    Sarosiek, Shayna
    Sanchorawala, Vaishali
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (09) : 1823 - 1827
12345